- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.01. | Range Impact, Inc.: Range Impact Announces Two Major Land Acquisitions in Kentucky and Sale of Abandoned Mine Land Services Business | 73 | GlobeNewswire (Europe) | CLEVELAND, OHIO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public company dedicated to acquiring, reclaiming and repurposing distressed... ► Artikel lesen | |
| RANGE IMPACT Aktie jetzt für 0€ handeln | |||||
| 07.01. | RANGE IMPACT, INC. - 8-K, Current Report | - | SEC Filings | ||
| 14.11.25 | Range Impact reports Q3 results | 2 | Seeking Alpha | ||
| 14.11.25 | Range Impact, Inc.: Range Impact Reports 3Q 2025 Financial Results | 143 | GlobeNewswire (Europe) | Cleveland, Ohio, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public impact investing company dedicated to acquiring, reclaiming and repurposing... ► Artikel lesen | |
| 14.11.25 | RANGE IMPACT, INC. - 8-K, Current Report | - | SEC Filings | ||
| 14.11.25 | RANGE IMPACT, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 24.09.25 | Range Impact raises $550,000 | 1 | Seeking Alpha | ||
| 24.09.25 | Range Impact, Inc.: Range Impact Announces $550,000 Capital Raise | 1 | GlobeNewswire (USA) | ||
| 24.09.25 | RANGE IMPACT, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.08.25 | Range Impact GAAP EPS of -$0.01, revenue of $1.39M | 3 | Seeking Alpha | ||
| 14.08.25 | RANGE IMPACT, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 14.08.25 | Range Impact, Inc.: Range Impact Reports 2Q 2025 Financial Results | 174 | GlobeNewswire (Europe) | Cleveland, Ohio, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public impact investing company dedicated to acquiring, reclaiming and repurposing... ► Artikel lesen | |
| 14.08.25 | RANGE IMPACT, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.07.25 | Range Impact, Inc.: Range Impact Announces Expansion of Investment in its Fola Mine Complex with Acquisition of Two Mining Permits and Two Coal Leases | 222 | GlobeNewswire (Europe) | CLEVELAND, OHIO, July 02, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public company dedicated to acquiring, reclaiming and repurposing distressed... ► Artikel lesen | |
| 15.05.25 | Range Impact, Inc.: Range Impact Reports 1Q 2025 Financial Results | 150 | GlobeNewswire (Europe) | Cleveland, Ohio, May 15, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public impact investing company dedicated to acquiring, reclaiming and repurposing... ► Artikel lesen | |
| 02.04.25 | Range Impact, Inc.: Range Impact Announces Major Land Acquisition in West Virginia | 177 | GlobeNewswire (Europe) | CLEVELAND, OHIO, April 02, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public company dedicated to acquiring, reclaiming and repurposing distressed... ► Artikel lesen |
16 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 50,05 | -0,04 % | Streit um Diabetes-Markt: Milliarden-Blockbuster unter Beschuss: Klage könnte Novo teuer zu stehen kommen | © Foto: SOPA Images - Sipa USAEine Klage wirft Novo Nordisk vor, günstige Generika jahrelang blockiert zu haben. Im Zentrum steht ein Deal und der Milliardenumsatz eines Diabetesmittels.Der dänische... ► Artikel lesen | |
| AURORA CANNABIS | 3,450 | +0,58 % | CBD-Markt auf Wachstumskurs: Neural Therapeutics und Hanf.com positionieren sich strategisch | ||
| CANOPY GROWTH | 0,932 | +0,32 % | Should You Buy Canopy Growth Stock Before Feb. 6? | ||
| TILRAY BRANDS | 6,310 | +0,32 % | TILRAY BRANDS INC: Stabilität als Grundlage für den nächsten Schritt | ||
| VERTEX PHARMACEUTICALS | 397,60 | +0,26 % | Prediction: 2026 Will Be the Year of Vertex Pharmaceuticals | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | TAAT Global Alternatives Inc (2): TAAT Global CEO Saxon resigns | ||
| CRONOS GROUP | 2,150 | +1,70 % | Cronos Group Inc.: Cronos to enter the Netherlands with acquisition of Europe's largest adult-use cannabis company | Cronos to acquire CanAdelaar for up-front cash consideration of US$67.0M1 plus cash earnout of 0.5x normalized EBITDA in 2026 and 2027 Up-front consideration represents approximately 1.4x CanAdelaar... ► Artikel lesen | |
| DIGICANN VENTURES | 0,006 | -72,50 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| EYEPOINT | 11,795 | +3,37 % | EyePoint Pharmaceuticals, Inc.: EyePoint Reports Corporate Update and Anticipated Pivotal Milestones for 2026 | - Phase 3 programs underway for DURAVYU in wet AMD and DME, the largest multi-billion-dollar retinal disease markets - - Pivotal Phase 3 trials in wet AMD on track for data readout beginning in mid-2026... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,310 | +3,15 % | Organigram Global Inc: Organigram increases Phylos loan by $3-million (U.S.) | ||
| GREEN THUMB INDUSTRIES | 5,615 | -1,49 % | Why Green Thumb Industries Could Be Among the Biggest Winners From Marijuana Rescheduling | ||
| MYDECINE INNOVATIONS GROUP | 0,279 | +117,12 % | Mydecine Innovations Group Inc (3): Mydecine Innovations to change name to Noveris Health | ||
| SANTHERA PHARMACEUTICALS | 13,860 | +0,43 % | Santhera Pharmaceuticals Holding AG: Santhera erhält Swissmedic-Zulassung für AGAMREE (Vamorolon) zur Behandlung von Duchenne-Muskeldystrophie | Markteinführung in der Schweiz für das zweite Halbjahr 2026 erwartet
Pratteln, Schweiz, 15. Januar 2026 - Santhera Pharmaceuticals (SIX: SANN) gibt bekannt, dass die Schweizerische Heilmittelbehörde... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 14,600 | 0,00 % | Tonix Presents Positive Phase 3 RESILIENT Data On TONMYA At 2026 Non-Opioid Pain Therapeutics Summit | ||
| NEKTAR THERAPEUTICS | 31,600 | 0,00 % | Where Nektar Therapeutics Stands With Analysts |
Das Unternehmen RANGE IMPACT INC kann der Branche Pharma zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RANGE IMPACT INC finden Sie auf Wallstreet Online.